Inland Real Estate Incomeの空売り状況は、投資家がInland Real Estate Incomeの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Inland Real Estate Income (OTC:INRE) 株価情報, 空売り情報

Inland Real Estate Income Trust Inc is a real estate investment trust formed to acquire a portfolio of commercial real estate properties in the United States. The Company has one reportable segment which includes retail real estate. The company acquires retail properties, office buildings, multi-family properties, industrial and distribution, and warehouse facilities. The revenue from the Company's properties consists of rents received under long-term operating leases.

INLAND REAL EST INC TR by Inland Real Estate Income Tr Inc

Inland Real Estate Income Trust Inc

InRetail Peru Corp

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) rallied 17% over the past week, spurred by speculation around <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42152684/musk-tweet-sparks-dogecoin-surge-fuels-speculation-on-x-payments">Elon Musk's X Payments platform</a> potentially incorporating DOGE.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.4254</td>
<td>$62.5 Billion</td>
<td>&nbsp;+2.3%</td>
<td>&nbsp;+17%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00002593  </td>
<td>$15.3 Billion</td>
<td>+2.7%</td>
<td>&nbsp;+5.9%</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>$0.0000202</td>
<td>$8.5 Billion</td>
<td>+1.5%</td>
<td>&nbsp;-3.4%</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$98,129.53</td>
<td>$1.94 Trillion</td>
<td>+0.7%</td>
<td>+8.4%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Macro guru Raoul Pal highlighted that Dogecoin has outperformed Bitcoin by surging 550% since its launch, calling it &#8220;harder money&#8221; in this context and predicting potential continued outperformance.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">One of the most WILD things in all of crypto is that <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> has proven to be harder money than <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> and has outperformed by 550% since launch (10 years!) and looks like it might even to continue to outperform over time!&#x1f923; What a time to be alive&#8230; <a href="https://t.co/3EXQFEzPsb">pic.twitter.com/3EXQFEzPsb</a>
&mdash; Raoul Pal (@RaoulGMI) <a href="https://twitter.com/RaoulGMI/status/1860822834018181423?ref_src=twsrc%5Etfw">November 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Tardigrade expects DOGE to retrace to $0.30 before potentially spiking to $3, drawing <a href="https://x.com/TATrader_Alan/status/1860958108601966599">comparisons</a> to similar cycles from 2018-2021 and 2021-2025.
Crypto trader Master Kenobi sees a positive broader trend for DOGE but the timeline could shift, potentially influenced by changes in Bitcoin dominance. 
He added that the current market behavior resembles early January 2021 and if history repeats, volatility may follow, according to the trader. In the previous cycle, DOGE dropped 55% over two weeks, although such a drop isn&#8217;t guaranteed.
He <a href="https://x.com/btc_MasterPlan/status/1860790391332843921">suggests</a> a conservative target of $1 to $1.45 and noted that a green close this week would mark the second-longest streak of green weeks in DOGE's history (6 weeks, the record being 8 weeks in 2017-2018).
Statistics: IntoTheBlock data shows large transaction volume increasing by 41.1% and daily active addresses falling by 34.9%. 
Coinglass data shows liquidations at the lowest since Nov.2. Long liquidations stand at $3.74 million, short liquidations at $2.73 million. Open interest is at all time high levels of $3.95 billion.
Community News: Dogecoin spiked to $0.40 over the weekend after an Elon Musk tweet <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42152684/musk-tweet-sparks-dogecoin-surge-fuels-speculation-on-x-payments">sparked speculations</a> about the forthcoming X Payments service, which could potentially support transactions with digital assets like DOGE.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42152520/dogecoin-whales-move-214-5m-in-a-single-day-sparking-speculation">Dogecoin Whales Move $214.5M In A Single Day, Sparking Speculation</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

$DOGE

$PEPE

$SHIB

Dogecoin Is 'Harder Money' Than Bitcoin, Says Raoul Pal: Here's What The Numbers Say

WIIM

PLTR

Palantir Technologies shares are trading higher after Wedbush maintained an Outperform rating on the stock and raised its price target from $57 to $75.

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Gain Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GANX#NASDAQ">GANX</a>) with a Buy and maintains $8 price target.

Price Target

Reiteration

Analyst Ratings

GANX

HC Wainwright & Co. Reiterates Buy on Gain Therapeutics, Maintains $8 Price Target

D. Boral Capital analyst Jesse Sobelson maintains EON Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EONR#AMEX">EONR</a>) with a Buy and lowers the price target from $6 to $4.5.

EONR

D. Boral Capital Maintains Buy on EON Resources, Lowers Price Target to $4.5

Baird analyst Justin Kleber maintains Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) with a Outperform and raises the price target from $35 to $40.

CHWY

Baird Maintains Outperform on Chewy, Raises Price Target to $40

CGTX

Cognition Therapeutics shares are trading higher after the company provided an update on a biomarker analysis from the Phase 2 SHINE study in mild-to-moderate Alzheimer's disease.

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) with a Buy and maintains $15 price target.

ABEO

HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $15 Price Target

Northland Capital Markets analyst Ted Jackson downgrades Xos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOS#NASDAQ">XOS</a>) from Outperform to Market Perform and lowers the price target from $9 to $5.

Downgrades

Northland Capital Markets Downgrades Xos to Market Perform, Lowers Price Target to $5

WestPark Capital analyst Paul Rodriguez reiterates CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Hold.

CRWD

WestPark Capital Reiterates Hold on CrowdStrike Holdings

Rosenblatt analyst Barton Crockett maintains Quad/Graphics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QUAD#NYSE">QUAD</a>) with a Buy and raises the price target from $7.7 to $10.3.

QUAD

Rosenblatt Maintains Buy on Quad/Graphics, Raises Price Target to $10.3

"Alarum's fourth quarter 2024 revenues are estimated at $7.5 million ±3% and Adjusted EBITDA for the fourth quarter 2024 is expected to range from $1.3 million to $1.7 million."

Guidance

ALAR

Alarum Technologies Expects Q4 Revenue Of $7.5M ±3% Vs $7.48M Est

HC Wainwright &amp; Co. analyst Mitchell Kapoor maintains CARISMA Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARM#NASDAQ">CARM</a>) with a Buy and lowers the price target from $8 to $5.

CARM

HC Wainwright & Co. Maintains Buy on CARISMA Therapeutics, Lowers Price Target to $5

ELAB

Elevai Labs shares are trading lower after the company announced a 1-for-200 reverse stock split.

SNOW

Snowflake shares are trading higher after Wedbush upgraded the stock from Neutral to Outperform.

UXIN

Uxin shares are trading higher after the company reported Q2 sales of $70.85 million, up from $48.80 million year-over-year.

Macy's shares are trading lower after the company delayed its Q3 earnings release and conference call, citing an issue related to delivery expenses in one of its accrual accounts, prompting an independent investigation.

BBWI

Bath & Body Works shares are trading higher after the company reported better-than-expected Q3 EPS and sales and raised its 2024 guidance.

Rosenblatt analyst Catharine Trebnick maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Buy and raises the price target from $325 to $385.

Rosenblatt Maintains Buy on CrowdStrike Holdings, Raises Price Target to $385

The study is evaluating the safety, tolerability, efficacy, pharmacokinetics, and biomarkers of orally administered PL8177 in adult patients with active ulcerative colitis.

Biotech

Health Care

General

Palatin Technologies Has Completed Enrollment In Its Phase 2 Study Of PL8177 For Ulcerative Colitis, The Last Patient Visit Is Expected To Occur In Q1 Of 2025, With Topline Data Expected Shortly Thereafter

HC Wainwright &amp; Co. analyst Mitchell Kapoor initiates coverage on Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Sell rating and announces Price Target of $80.

Initiation

SRPT

HC Wainwright & Co. Initiates Coverage On Sarepta Therapeutics with Sell Rating, Announces Price Target of $80

Inland Real Estate ate Income Trust (INRE) has released an update to notify the public and investors about its officers. Daniel L. Goodwin, the lon...

Inland Real Estate Elects New Chairman, Honors Late Goodwin

Inland Real Estate ate Income Trust (INRE) has issued an announcement. Inland Real Estate Income Trust, Inc. has informed financial advisors and br...

Inland Real Estate Sets New NAV at $19.17 per Share

The latest announcement is out from Inland Real Estate ate Income Trust ( ($INRE) ). Inland Real Estate Income Trust, Inc. is exploring strategic a...

Comments

Inland Real Estate Income

空売り

Inland Real Estate Income (OTC:INRE) 株価情報, 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル